Does Medicaid Cover GLP-1 Drugs in 2026?
Medicaid can cover GLP-1 medications, but coverage depends on the drug, why it was prescribed and your state’s Medicaid rules. GLP-1 drugs prescribed for medically accepted indications such as type 2 diabetes are generally covered under Medicaid’s prescription-drug rules, although prior authorization and other requirements may apply. Coverage specifically for obesity or weight loss is different: states can choose whether to cover weight-loss drugs. As of January 2026, KFF identified only 13 state Medicaid fee-for-service programs covering GLP-1 drugs for obesity.
Does Medicaid Pay for GLP-1 Medications?
Yes, Medicaid covers many GLP-1 medications—but there is an important catch.
The answer depends heavily on the medical indication for which the drug is prescribed.
Under the Medicaid Drug Rebate Program, states generally must cover participating manufacturers’ FDA-approved drugs for medically accepted indications.
However, federal Medicaid law includes an exception allowing states to exclude certain drugs used for weight loss.
GLP-1 prescribed for a covered medically accepted indication such as type 2 diabetes → Medicaid coverage is generally required, subject to program rules.
GLP-1 prescribed specifically for obesity/weight loss → coverage depends much more heavily on your state.
Which GLP-1 Drugs Could Medicaid Cover?
GLP-1 and related incretin medications commonly discussed by Medicaid members include:
| Drug | Active Ingredient | Commonly Associated Use | Medicaid Coverage Issue |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | Coverage differs from use solely for weight loss. |
| Wegovy | Semaglutide | Weight management; also has other FDA-approved indications | Coverage depends on indication and state rules. |
| Mounjaro | Tirzepatide | Type 2 diabetes | Coverage differs from weight-loss-only use. |
| Zepbound | Tirzepatide | Weight management; obstructive sleep apnea in certain adults | Coverage depends on indication and state policy. |
| Rybelsus | Semaglutide | Type 2 diabetes | State formulary and utilization requirements can apply. |
The same active ingredient may be marketed under different brand names for different FDA-approved indications. Medicaid can therefore treat a prescription for diabetes differently from one prescribed solely for weight management.
Does Medicaid Cover Ozempic?
Medicaid generally covers Ozempic for an appropriate medically accepted indication such as type 2 diabetes, subject to the state’s preferred drug list, prior authorization rules and other utilization controls.
Ozempic should not automatically be treated as a Medicaid-covered weight-loss drug simply because weight reduction can occur while taking it.
The diagnosis and medically accepted indication matter.
Does Medicaid Cover Mounjaro?
Mounjaro is another medication where the reason for the prescription is critical.
Its established FDA-approved indication includes treatment of type 2 diabetes.
State Medicaid programs can still impose appropriate utilization management requirements, including prior authorization.
Does Medicaid Cover Wegovy?
This answer is more complicated.
Wegovy is associated with chronic weight management, but it also has FDA-approved indications beyond weight reduction alone.
For example, coverage rules can differ when Wegovy is prescribed for an FDA-approved cardiovascular indication rather than solely for weight loss.
For weight management alone, Medicaid coverage remains highly state-specific.
Does Medicaid Cover Zepbound?
Zepbound is FDA-approved for chronic weight management and also has an FDA-approved indication involving moderate-to-severe obstructive sleep apnea in adults with obesity.
That distinction can matter enormously for Medicaid coverage.
A state that does not cover Zepbound solely for weight loss may still have coverage obligations or rules for another medically accepted FDA-approved indication.
Does Medicaid Cover GLP-1 Drugs for Weight Loss?
Only in some states.
This is where Medicaid GLP-1 coverage becomes particularly confusing.
KFF’s January 2026 analysis found only 13 state Medicaid fee-for-service programs covering GLP-1 medications for obesity treatment.
Coverage had actually decreased from 16 states reported in October 2025 as several states eliminated or restricted obesity-drug coverage.
State policies have been changing rapidly because of drug costs, budgets, new FDA indications and new federal initiatives.
Why Doesn’t Every Medicaid Program Cover GLP-1s for Obesity?
Federal law treats weight-loss drugs differently from most other outpatient prescription medications in Medicaid.
States are permitted to exclude drugs when used for weight loss.
Cost is also a major issue.
GLP-1 utilization and Medicaid spending have increased substantially in recent years, creating budget pressure for state Medicaid programs.
As a result, states have taken very different approaches.
Which States Cover GLP-1 Drugs for Weight Loss?
There is no permanent nationwide list because state Medicaid policies can change during the year.
KFF identified 13 fee-for-service Medicaid programs covering GLP-1s for obesity treatment as of January 2026.
But even in a state that covers obesity treatment, that does not mean every Medicaid member automatically qualifies.
Coverage may involve:
- Prior authorization
- Specific BMI criteria
- Documented medical conditions
- Clinical eligibility requirements
- Required lifestyle interventions
- Preferred-drug requirements
- Renewal requirements
Use your state’s current Medicaid preferred drug list/formulary and prior-authorization criteria, or contact the Medicaid managed-care plan listed on your member card.
Why Prior Authorization Matters
Seeing a GLP-1 medication on a Medicaid drug list does not necessarily mean you can fill the prescription immediately.
Many states use prior authorization.
This means the prescriber may have to send information showing that you meet the Medicaid program’s clinical requirements before the pharmacy claim is approved.
| Pharmacy Situation | What It Could Mean |
|---|---|
| Prescription approved immediately | Drug and indication may meet current coverage rules. |
| Prior authorization required | Prescriber may need to submit clinical information. |
| Drug not preferred | Program may prefer another medication first. |
| Diagnosis restriction | Coverage may require an eligible medical indication. |
| Weight-loss exclusion | Your state may not currently cover the drug solely for obesity. |
What Is the New Medicaid BALANCE Program?
There is an important new development for 2026.
CMS created the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model.
The voluntary program is designed to expand access to selected GLP-1 medications and lifestyle interventions for people with Medicaid and Medicare.
For Medicaid, participating state programs can join the model on a rolling basis beginning in May 2026 through January 1, 2027.
Does BALANCE Mean Medicaid Now Covers GLP-1s Everywhere?
No.
This distinction is extremely important.
Participation is voluntary for state Medicaid agencies and drug manufacturers.
CMS explicitly states that coverage depends on participation and that the model does not guarantee coverage for an individual patient.
Your state must participate, the applicable manufacturer must participate, and you must meet the program’s eligibility and coverage requirements.
Which Drugs Are Included in BALANCE?
CMS currently lists formulations involving several well-known medications in the BALANCE Model, including:
- Mounjaro
- Ozempic
- Rybelsus
- Wegovy
- Zepbound — specified formulation
- Other eligible products identified by CMS
The model includes participating products for currently covered indications as well as qualifying weight-management indications under the model’s terms.
Does BALANCE Include Lifestyle Support?
Yes.
CMS says Medicaid beneficiaries receiving GLP-1 treatment for weight management through BALANCE will also receive access to a lifestyle support program.
The program is intended to provide education and support involving nutrition, physical activity and maintaining weight loss.
CMS says the manufacturer provides the lifestyle support at no cost to the patient under the model.
What About California Medicaid?
California demonstrates why readers must check their current state rules rather than relying on a generic national answer.
Effective January 1, 2026, Medi-Cal changed its coverage of GLP-1 drugs used for weight loss.
California says Wegovy, Zepbound and Saxenda are no longer covered when used for weight loss alone.
Drugs including Ozempic and Mounjaro also are not covered simply for weight-loss use, while coverage can continue for qualifying non-weight- loss indications subject to program requirements.
“Medicaid covers Ozempic” and “Medicaid covers Ozempic for weight loss” are not equivalent statements.
Can Children on Medicaid Get GLP-1 Coverage?
Children and adolescents enrolled in Medicaid have additional protections through the Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit.
EPSDT requires coverage of medically necessary services for eligible Medicaid beneficiaries under age 21 when federal requirements are met.
That can produce different coverage results from the rules applied to adults.
For example, California’s 2026 guidance says a member younger than 21 who needs a GLP-1 drug for weight loss can continue to receive coverage when an appropriate prior-authorization request is submitted and approved under EPSDT requirements.
How Do I Find Out If My Medicaid Covers My GLP-1?
Check whether the prescription is for Ozempic, Wegovy, Mounjaro, Zepbound or another medication.
Ask your prescriber what medical indication is being submitted with the prescription. Diabetes, obesity, cardiovascular disease and sleep apnea can produce different coverage outcomes.
Look for the current Medicaid preferred drug list or your managed-care plan’s pharmacy formulary.
Determine whether your doctor needs to submit additional medical information.
The new CMS model can change weight-management access in participating states.
A denial may involve the indication, prior authorization, formulary status or another requirement rather than a universal Medicaid ban.
What If Medicaid Denies My GLP-1 Prescription?
First determine the exact reason for the denial.
Ask whether the problem is:
- Missing prior authorization
- Diagnosis restriction
- Non-preferred medication
- Weight-loss exclusion
- Missing clinical documentation
- Eligibility issue
- Another pharmacy-claim requirement
Your prescriber may be able to submit the required documentation, request prior authorization or discuss another covered treatment when appropriate.
Coverage rules and medical suitability are separate questions. Discuss medication changes with your healthcare professional.
Does Medicaid Cover GLP-1? Quick Answers
| Question | Answer |
|---|---|
| Does Medicaid cover GLP-1 drugs? | Yes for many medically accepted indications, subject to state coverage and utilization rules. |
| Does Medicaid cover GLP-1 for weight loss? | Only in some states or through qualifying coverage arrangements. |
| How many states covered GLP-1s for obesity in January 2026? | 13 fee-for-service Medicaid programs, according to KFF. |
| Does Medicaid cover Ozempic? | Generally for appropriate covered indications such as type 2 diabetes, subject to state rules. |
| Does Medicaid cover Wegovy? | It depends on the indication and state policy. |
| Does Medicaid cover Mounjaro? | Coverage is generally available for appropriate covered indications such as type 2 diabetes, subject to state rules. |
| Does Medicaid cover Zepbound? | Coverage depends on the indication and state rules; weight-loss-only coverage is not universal. |
| What is BALANCE? | A voluntary CMS model intended to expand access to selected GLP-1 medications and lifestyle interventions. |
| Does BALANCE guarantee coverage? | No. |
| Can prior authorization be required? | Yes, and it is common for GLP-1 coverage. |
Bottom Line
The answer to “Does Medicaid cover GLP-1?” depends primarily on why the medication was prescribed and where you live.
Medicaid generally covers GLP-1 drugs for qualifying medically accepted indications such as type 2 diabetes, although formulary and prior-authorization requirements can apply.
Coverage solely for obesity or weight management is much less consistent because federal law allows states to exclude weight-loss drugs.
As of January 2026, KFF identified only 13 state Medicaid fee-for-service programs covering GLP-1s for obesity.
CMS’s new BALANCE Model could expand access in participating states during 2026, but it does not create automatic nationwide coverage.
For the most accurate answer, check your state’s current Medicaid formulary using the exact drug and medical indication on your prescription.
Authoritative Sources
Medicaid.gov
Medicaid Prescription Drug Coverage
Centers for Medicare & Medicaid Services
CMS BALANCE Model
Last reviewed: October 7, 2026. Medicaid drug coverage can change and differs by state, managed-care plan, drug and medical indication. Verify current coverage with your Medicaid program or health plan. This article provides coverage information and is not medical advice. BillUnpacked is an independent informational website and is not affiliated with Medicaid, CMS or any drug manufacturer.